Hansa Biopharma AB certified as a Great Place to Work[® ]
Based on the results of a company-wide employee survey and a review of policies, Hansa Biopharma has been officially awarded the Great Place to Work certificate by the Great Place to Work InstituteLund, Sweden September 11, 2020. Hansa Biopharma AB (“Hansa”), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its certification as a Great Place to Work 2020 by the independent institute Great Place to Work®, a global authority on workplace culture and leadership behaviour. The certification was primarily based on ratings provided by Hansa